Ibrutinib as Initial Therapy for Elderly Patients With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma: An Open-Label, Multicentre, Phase 1b/2 Trial
The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(13)70513-8
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2014
Authors
Publisher
Elsevier BV